PAHC vs PINC: fair value comparison
Phibro Animal Health Corporation and Premier, Inc. · Updated 2026-10-19
PINC has no fair-value estimate yet: no usable analyst consensus or too few reported quarters. Within Healthcare, PAHC currently ranks higher by quality score.
| PAHC | PINC | |
|---|---|---|
| Verdict | Undervalued | No estimate yet |
| Last price | $38.82 | $49.24 |
| 12-month range | $28.52–$59.58 | $49.05–$49.80 |
| Rank by discount to fair value | #37 of 108 Healthcare | — |
| Rank by quality score | #114 of 301 Healthcare | #115 of 301 Healthcare |
| Quality grade | C | C |
| Leverage | High | Low |
| Margin trend | Expanding | Expanding |
| Revenue growth | Strong | Declining |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Mixed | Uptrend |
| 52-week position | The lower-middle quarter | The lower-middle quarter |
Full single-stock breakdowns: PAHC fair value analysis · PINC fair value analysis